Children and COVID-19: Microbiological and immunological insights

Danilo Buonsenso; Michela Sali; Davide Pata; Cristina De Rose; Maurizio Sanguinetti; Piero Valentini; Giovanni Delogu

doi:10.1002/ppul.24978

Children and COVID-19: Microbiological and immunological insights

Danilo Buonsenso, Michela Sali, Davide Pata, Cristina De Rose, Maurizio Sanguinetti, Piero Valentini, Giovanni Delogu

Research output: Contribution to journal › Review article › peer-review

Abstract

Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS-CoV-2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS-CoV-2 infection in children highlighting the main differences from adult SARS-CoV-2 infection.

Original language	English
Pages (from-to)	2547-2555
Number of pages	9
Journal	Pediatric Pulmonology
Volume	55
Issue number	10
DOIs	https://doi.org/10.1002/ppul.24978
Publication status	Published - Oct 1 2020

Keywords

children
COVID-19
immunology
novel coronavirus
SARS-CoV-2

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Pulmonary and Respiratory Medicine

Access to Document

10.1002/ppul.24978

Fingerprint Dive into the research topics of 'Children and COVID-19: Microbiological and immunological insights'. Together they form a unique fingerprint.

Cite this

@article{432b5ce400d54414b23de826c57b7ec8,

title = "Children and COVID-19: Microbiological and immunological insights",

abstract = "Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS-CoV-2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS-CoV-2 infection in children highlighting the main differences from adult SARS-CoV-2 infection.",

keywords = "children, COVID-19, immunology, novel coronavirus, SARS-CoV-2",

author = "Danilo Buonsenso and Michela Sali and Davide Pata and {De Rose}, Cristina and Maurizio Sanguinetti and Piero Valentini and Giovanni Delogu",

year = "2020",

month = oct,

day = "1",

doi = "10.1002/ppul.24978",

language = "English",

volume = "55",

pages = "2547--2555",

journal = "Pediatric Pulmonology",

issn = "8755-6863",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - Children and COVID-19

T2 - Microbiological and immunological insights

AU - Buonsenso, Danilo

AU - Sali, Michela

AU - Pata, Davide

AU - De Rose, Cristina

AU - Sanguinetti, Maurizio

AU - Valentini, Piero

AU - Delogu, Giovanni

PY - 2020/10/1

Y1 - 2020/10/1

N2 - Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS-CoV-2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS-CoV-2 infection in children highlighting the main differences from adult SARS-CoV-2 infection.

AB - Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS-CoV-2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS-CoV-2 infection in children highlighting the main differences from adult SARS-CoV-2 infection.

KW - children

KW - COVID-19

KW - immunology

KW - novel coronavirus

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85088786440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088786440&partnerID=8YFLogxK

U2 - 10.1002/ppul.24978

DO - 10.1002/ppul.24978

M3 - Review article

C2 - 32710652

AN - SCOPUS:85088786440

VL - 55

SP - 2547

EP - 2555

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 10

ER -